carbachol has been researched along with Neoplasms, Nervous System in 4 studies
Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
Excerpt | Relevance | Reference |
---|---|---|
" The effect of mastoparan, a wasp venom toxin, on intracellular free Ca2+ concentration ([Ca2+]i) was examined in human astrocytoma cells." | 7.69 | Dual effects of mastoparan on intracellular free Ca2+ concentrations in human astrocytoma cells. ( Ishimoto, H; Mizuno, K; Nakahata, N; Nakanishi, H; Ohizumi, Y, 1994) |
" The effect of mastoparan, a wasp venom toxin, on intracellular free Ca2+ concentration ([Ca2+]i) was examined in human astrocytoma cells." | 3.69 | Dual effects of mastoparan on intracellular free Ca2+ concentrations in human astrocytoma cells. ( Ishimoto, H; Mizuno, K; Nakahata, N; Nakanishi, H; Ohizumi, Y, 1994) |
" In a well-characterized human oligodendroglioma (HOG) cell line, PL-C (measured by release of [3H]inositol phosphates) and PL-D (formation of [3H]myristoylated or palmitoylated phosphatidylethanol) were activated by both carbachol (blocked by pirenzepine, suggesting an M1 receptor) and histamine (H1 receptor) but not glutamate, bradykinin, or phenylephrine." | 3.68 | Regulation of phospholipase D activity in a human oligodendroglioma cell line (HOG). ( Dawson, G; Dawson, SA; Post, GR, 1993) |
"The addition of bradykinin to populations of fura-2 loaded N1E-115 neuroblastoma cells produced an increase in intracellular calcium which rapidly reached a peak and returned to baseline within 60 s." | 3.68 | Agonist-induced changes in [Ca2+]i in N1E-115 cells: differential effects of bradykinin and carbachol. ( Hill, SJ; Iredale, PA; Kendall, DA; Martin, KF, 1992) |
"The effect of calcium channel antagonists on depolarization and carbachol evoked release of [3H]noradrenaline in the human neuroblastoma, SH-SY5Y, was investigated." | 3.68 | The effect of calcium channel antagonists on the release of [3H]noradrenaline in the human neuroblastoma, SH-SY5Y. ( Ball, SG; Murphy, NP; Vaughan, PF, 1991) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nakahata, N | 1 |
Ishimoto, H | 1 |
Mizuno, K | 1 |
Ohizumi, Y | 1 |
Nakanishi, H | 1 |
Dawson, G | 1 |
Dawson, SA | 1 |
Post, GR | 1 |
Iredale, PA | 1 |
Martin, KF | 1 |
Hill, SJ | 1 |
Kendall, DA | 1 |
Murphy, NP | 1 |
Ball, SG | 1 |
Vaughan, PF | 1 |
4 other studies available for carbachol and Neoplasms, Nervous System
Article | Year |
---|---|
Dual effects of mastoparan on intracellular free Ca2+ concentrations in human astrocytoma cells.
Topics: Astrocytoma; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Carbachol; Fura-2; GTP-Bin | 1994 |
Regulation of phospholipase D activity in a human oligodendroglioma cell line (HOG).
Topics: Alkaloids; Carbachol; Chromatography, Thin Layer; Down-Regulation; Enzyme Activation; Histamine; Hum | 1993 |
Agonist-induced changes in [Ca2+]i in N1E-115 cells: differential effects of bradykinin and carbachol.
Topics: Bradykinin; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Carbachol; Fura-2; Humans; | 1992 |
The effect of calcium channel antagonists on the release of [3H]noradrenaline in the human neuroblastoma, SH-SY5Y.
Topics: Calcium Channel Blockers; Carbachol; Cations, Divalent; Cell Line; Humans; Nervous System Neoplasms; | 1991 |